Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phas...
Q1 2026
May 12, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Oct 30, 2025
Q2 2025
Aug 25, 2025